Volume : 13, Issue : 10, October – 2026
Title:
DEVELOPMENT AND IN VITRO EVALUATION OF FLOATING DRUG DELIVERY SYSTEM OF DILTIAZEM HYDROCHLORIDE
Authors :
Dr. G. Sri Lakshmi, Mekala uday kiran, Arrolla Vaishnavi, Appanagari Varshini, Reddy pelli Venu, Pasham Venu, Zakiya sultana
Abstract :
The present study was undertaken to formulate and evaluate floating tablets of Diltiazem Hydrochloride for sustained drug release and prolonged gastric retention. FTIR studies revealed no significant interaction between the drug and excipients, indicating good compatibility. The powder blends exhibited satisfactory flow properties suitable for tablet compression. The prepared tablets showed acceptable hardness, thickness, friability, weight variation, and drug content values within pharmacopeial limits. Floating studies demonstrated that all formulations exhibited rapid buoyancy with floating lag times ranging from 42 to 49 seconds.In vitro dissolution studies revealed sustained drug release over a period of 8 hours. Among the developed formulations, F3 exhibited the highest cumulative drug release (97.83%) and the shortest floating lag time (42 seconds), indicating superior formulation performance. Accelerated stability studies conducted on the optimized formulation (F3) for 90 days under different storage conditions showed no significant changes in drug release characteristics, confirming the stability of the formulation.The results of the study suggest that the developed floating tablets of Diltiazem Hydrochloride provide effective gastroretentive behavior and sustained drug release. Therefore, the optimized formulation represents a promising gastroretentive drug delivery system that may enhance therapeutic efficacy, prolong gastric residence time, and improve patient compliance.
Keywords: Diltiazem Hydrochloride, Floating Tablets, Gastroretentive Drug Delivery System, Ethyl Cellulose, Eudragit RS100, Sustained Release, In Vitro Drug Release, Stability Studies.
Cite This Article:
Please cite this article in press G. Sri Lakshmi et al., Development And In Vitro Evaluation Of Floating Drug Delivery System Of Diltiazem Hydrochloride.,. Indo Am. J. P. Sci, 2026; 13(10).
REFERENCES:
1. Bagherwal A, Patidar DK, Sharma P. Formulation and evaluation of floating tablets of ciprofloxacin hydrochloride. Int J Comp Pharma 2010;1:1-4.
2. Kumar R. Development and in-vitro evaluation of sustained release floating matrix tablets of metformin hydrochloride. Int J Pharm Sci Res 2010;1:96-101.
3. Chodavarapu NP, Yendluri RB, Suryadevara H, Reddy P, Chhatoi P. Formulation and evaluation of abelmoschusesculentus mucilage based metformin hydrochloride floating matrix tablets. Int J Pharm Tech 2011;3:2725-45.
4. Kshirsagar RV, Jain V, Wattamwar S. Effect of different viscocity grade HPMC polymer on gastroretantive drug delivery of metformin hydrochloride. Int J Appl Pharm 2009; 1:44-50.
5. Chandiran IS, Kumar BP, Narayan V. Formulation and in-vitro evaluation of floating drug delivery system for salbutamol sulphate. Int J Pharm Biomed Sci 2010; 1(1):12-15.
6. Hu L, Li L, Yang X, Liu W, Yang J, Jia Y, et al., Floating matrix dosage form for dextromethorphan hydrobromide based on gas forming technique. In-vitro and in-vivoevalvation healthy volunteers. Eur J Pharm Sci 2011;42:99-105.
7. Raju BD, Sreenivas R, Varma MM. Formulation and evaluation of floating drug delivery system of metformin hydrochloride. J Chem Pharm Res 2010;2(2):274-78.
8. Senthilkumar SK, Jaykar B, Kavimani S. Formulation and evaluation of gastroretentive floating drug delivery system of rabeprazole sodium. Int J Biopharm 2011;2(2):57-62.
9. Mohammed MS. Formulation and in-vitro evaluation of sustained release intragastric tablets of propranolol hydrochloride using natural polymer. J Pharm Biomed Sci 2011;10(10):1-10.
10. Goole J, Vanderbist F, Amighi K. Development and evaluation of new multi-unit levodopa sustained-release floating dosage forms. Ind J Pharm 2007;334:35-41.
11. Sauzet C, Bruno CM, Nicolas M, Kister J, Piccerdle P, Prinderre P. An innovative floating gastro retentive dosage system. Formulation and in-vitro evaluation. Int J Pharm 2009;378:23-29.
12. Abrahamsson, B., Alpsten, M., Hugosson, M., Jonsson, U.E., Sundgren, M., Svenheden, A., Tölli, J., 1993. Absorption, Gastrointestinal Transit, and Tablet Erosion of Felodipine Extended-Release (ER) Tablets. Pharm. Res. 10, 709-714.
13. Agrawal, A.M., Manek, R.V., Kolling, W.M., Neau, S.H., 2003. Studies on the interaction of water with ethylcellulose: effect of polymer particle size. AAPS Pharm. Sci. Tech. 4, E60.
14. Alvisi, V., Gasparetto, A., Dentale, A., Heras, H., Felletti-Spadazzi, A., D’Ambrosi, A., 1996. Bioavailability of a controlled release formulation of ursodeoxycholic acid in man. Drugs Exp. Clin. Res. 22, 29-33.
15. Amaral, M.H., Lobo, J.M., Ferreira, D.C., 2001. Effect of hydroxypropyl methylcellulose and hydrogenated castor oil on naproxen release from sustained-release tablets. AAPS Pharm. Sci. Tech. 2, E6.
16. Andrews, G.P., Laverty, T.P., Jones, D.S., 2009. Mucoadhesive polymeric platforms for controlled drug delivery. Eur. J. Pharm. Biopharm. 71, 505-518.